Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 23;6(4):451-462.
doi: 10.1016/j.jcmgh.2018.07.004. eCollection 2018.

Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis

Octavia Pickett-Blakely  1 , Kimberly Young  1 , Rotonya M Carr  1
Affiliations
Review

Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis

Octavia Pickett-Blakely et al. Cell Mol Gastroenterol Hepatol. .

Abstract

Micronutrients include electrolytes, minerals, vitamins, and carotenoids, and are required in microgram or milligram quantities for cellular metabolism. The liver plays an important role in micronutrient metabolism and this metabolism often is altered in chronic liver diseases. Here, we review how the liver contributes to micronutrient metabolism; how impaired micronutrient metabolism may be involved in the pathogenesis of nonalcoholic fatty liver disease (NAFLD), a systemic disorder of energy, glucose, and lipid homeostasis; and how insights gained from micronutrient biology have informed NAFLD therapeutics. Finally, we highlight some of the challenges and opportunities that remain with investigating the contribution of micronutrients to NAFLD pathology and suggest strategies to incorporate our understanding into the care of NAFLD patients.

Keywords: ALT, alanine aminotransferase; BMI, body mass index; FXR, farnesoid X receptor; IL, interleukin; Micronutrients; NAFLD; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; Obesity; ROS, reactive oxygen species; TGF, transforming growth factor; Vitamins; carotenoids; minerals.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Micronutrients and the liver in NAFLD. Hepatic contribution to metabolism of the micronutrients involved in NAFLD pathogenesis. Vit., vitamin.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Carr R.M., Oranu A., Khungar V. Nonalcoholic fatty liver disease: pathophysiology and management. Gastroenterol Clin North Am. 2016;45:639–652. - PMC - PubMed
    1. Speliotes E.K., Yerges-Armstrong L.M., Wu J., Hernaez R., Kim L.J., Palmer C.D., Gudnason V., Eiriksdottir G., Garcia M.E., Launer L.J., Nalls M.A., Clark J.M., Mitchell B.D., Shuldiner A.R., Butler J.L., Tomas M., Hoffmann U., Hwang S.J., Massaro J.M., O'Donnell C.J., Sahani D.V., Salomaa V., Schadt E.E., Schwartz S.M., Siscovick D.S., Voight B.F., Carr J.J., Feitosa M.F., Harris T.B., Fox C.S., Smith A.V., Kao W.H., Hirschhorn J.N., Borecki I.B. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7 e1001324. - PMC - PubMed
    1. Romeo S., Kozlitina J., Xing C., Pertsemlidis A., Cox D., Pennacchio L.A., Boerwinkle E., Cohen J.C., Hobbs H.H. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461–1465. - PMC - PubMed
    1. Abul-Husn N.S., Cheng X., Li A.H., Xin Y., Schurmann C., Stevis P., Liu Y., Kozlitina J., Stender S., Wood G.C., Stepanchick A.N., Still M.D., McCarthy S., O'Dushlaine C., Packer J.S., Balasubramanian S., Gosalia N., Esopi D., Kim S.Y., Mukherjee S., Lopez A.E., Fuller E.D., Penn J., Chu X., Luo J.Z., Mirshahi U.L., Carey D.J., Still C.D., Feldman M.D., Small A., Damrauer S.M., Rader D.J., Zambrowicz B., Olson W., Murphy A.J., Borecki I.B., Shuldiner A.R., Reid J.G., Overton J.D., Yancopoulos G.D., Hobbs H.H., Cohen J.C., Gottesman O., Teslovich T.M., Baras A., Mirshahi T., Gromada J., Dewey F.E. A protein-truncating HSD17B13 variant and protection from chronic liver disease. N Engl J Med. 2018;378:1096–1106. - PMC - PubMed
    1. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., Grundy S.M., Hobbs H.H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395. - PubMed

Publication types

MeSH terms